Depression

When a person seeks information about treatment for themselves or their loved one, the importance of connecting them with the appropriate level of care right from the start cannot be overstated.

A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD) (RELIANCE-II)

Eligibility Criteria

•    Adults 18 to 65 years, inclusive.
•    Meets DSM-5 criteria for major depressive disorder.
•    Currently experiencing a major depressive episode.
•    Has had an inadequate response to current ongoing treatment with an approved antidepressant.
 

Exclusion Criteria
  • Treatment-resistant depression.
  • History of bipolar I or II disorder.
  • Any psychiatric condition which takes a primary focus of treatment over MDD.
  • Significant or poorly controlled concomitant medical illness.
  • Alcohol or other substance use disorder.
  • Pregnant, breast-feeding or planning to become pregnant or breast-feed during the study.
  • Significant risk of suicide.
State
Alabama
California
Connecticut
Florida
Georgia
Idaho
Maryland
Nevada
New Jersey
New York
Ohio
Pennsylvania
Texas

This is an outpatient, 2-arm, Phase 3, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of REL-1017 once daily (QD) as an adjunctive treatment of Major Depressive Disorder. Study participants will continue to take their current antidepressant therapy in addition to the study drug or placebo for the duration of the treatment period.

IRB approval #: 20210876

by Jessica Wendi Abel
When I was 9-months pregnant with my second baby, I tried to find a children’s picture book to read with my nearly five-year-old about a family living with the most common condition after childbirth—postpartum depression—and was shocked to find no book like this in 2020. I set out to create a resource for the 1 in 7 women who will experience postpartum depression along with their families. 
by Gordon Fraser
“As traumatized children, we always dreamed that someone would come and save us. We never dreamed that it would, in fact, be ourselves as adults.” – Alice Little 
by Daneisha Carter
My name is Daneisha and I'm an African American woman who suffers from severe anxiety and stress. I was around 18 years old when I had my first panic attack. I couldn't breathe and it felt like I was going to die.
by Carmen M. Tumialan Lynas, PhD
Most would agree that treating invasive cancer when it is still just the size of a mustard seed has a much better prognosis than waiting and treating it when it metastasizes into a larger, less curable disease. My cancer experience makes me more resolute about treating anxiety early. 
by Brandon Karasinski (AESTHETIC))
For many years music helped me to feel less alone going through something I hadn’t come to understand about myself until recently. My new song CARE describes that fork in the road we all come across in our lives where we have two paths to choose walking down.
by Eternal Ballers
In 2020, I made a life-altering decision to take my passion for music to a new level. This decision set me on a path of self-discovery, helping me overcome depression and anxiety while also aiming to assist others in their own journeys.
by Jamie Factor
My name is Jamie and I battle anxiety—social anxiety—and depression. As I write this, I am 18 and it's the middle of June. I'm going to college in a few months, which is something I never thought was possible.
by Min Jung
As I made connections between Buddhism and neuroscience, I realized they both shared a common insight: the need to retrain our brains and ourselves to value inner peace over fleeting pleasure, to find joy amidst challenges, and to discover happiness in the very process of living.